Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) - The ROSITEL Study

NACompletedINTERVENTIONAL

Enrollment

103

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

rosiglitazone

DRUG

metformin or sulfonylurea

Trial Locations (1)

Partners Research, Brampton